Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Candel Therapeutics, Inc. (CADL)
USD9.61
-0.26 (-2.63%)
US NASDAQ Healthcare Biotechnology
Address
117 Kendrick Street 2494
Needham, MA, US
Needham, MA, US
CEO
Paul-Peter Tak
Website
candeltx.com
IPO
2021-07-27
CIK 1841387 ISIN US1374041093
Description
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer. This therapy also successfully completed Phase Ib/II trials for high-grade glioma. Furthermore, the company is advancing CAN-3110, an investigational therapy currently in Phase I clinical trials for recurrent glioblastoma. Established in 2003, the company operated as Advantagene, Inc. until November 2020, when it rebranded as Candel Therapeutics, Inc.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD9.61
-0.26 (-2.63%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
-0.48
Float Shares
47.45M
Free Float %
86.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.34% | +13.07% | +74.71% | +56.87% | +92.03% | +57.70% | +66.85% | +456.88% | +27.29% | +27.29% | +27.29% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
9.61
Low
15.00
+56.1%
Consensus
15.00
+56.1%
Median
15.00
+56.1%
High
15.00
+56.1%
DCF (Unlevered)
2.20
-77.1%
DCF (Levered)
2.22
-76.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
89% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
15.00
+56.1%
|
| All Time | 1 |
15.00
+56.1%
|
Quality scores
Altman Z-Score
2.90
Grey zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+58.6% ★ Q1'26: -160.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+67.2% Q1'26: +96.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.04× Q1'26: -0.03× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 7 Rev. Ana. 6 EPS Ana. |
Dec 2029 3 Rev. Ana. 4 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
125.0K
est: 33.0K (+278.8%)
|
125.0K
est: 81.3K (+53.8%)
|
—
est: 15.5K (-100.0%)
|
—
est: 15.5K (-100.0%)
|
—
est: 4.35M (-100.0%)
|
92.50M
92.50M – 92.50M
+2,027.3% YoY
|
48.37M
48.37M – 48.37M
-47.7% YoY
|
185.50M
185.50M – 185.50M
+283.5% YoY
|
442.18M
442.18M – 442.18M
+138.4% YoY
|
763.83M
763.83M – 763.83M
+72.7% YoY
|
| EBITDA |
-25.49M
est: -6.6K (-386,231.3%)
|
-16.31M
est: -16.2K (-100,263.1%)
|
-37.43M
est: -3.1K (-1,207,741.2%)
|
-52.10M
est: 3.1K (-1,681,190.7%)
|
-47.42M
est: 869.6K (-5,553.0%)
|
18.50M
18.50M – 18.50M
+2,027.3% YoY
|
9.67M
9.67M – 9.67M
-47.7% YoY
|
37.10M
37.10M – 37.10M
+283.5% YoY
|
88.44M
88.44M – 88.44M
+138.4% YoY
|
152.77M
152.77M – 152.77M
+72.7% YoY
|
| EBIT |
-25.73M
est: -6.6K (-389,746.9%)
|
-17.09M
est: -16.2K (-105,051.1%)
|
-38.39M
est: -3.1K (-1,238,719.0%)
|
-53.09M
est: 3.1K (-1,713,136.5%)
|
-48.27M
est: 869.6K (-5,650.1%)
|
18.50M
18.50M – 18.50M
+2,027.3% YoY
|
9.67M
9.67M – 9.67M
-47.7% YoY
|
37.10M
37.10M – 37.10M
+283.5% YoY
|
88.44M
88.44M – 88.44M
+138.4% YoY
|
152.77M
152.77M – 152.77M
+72.7% YoY
|
| Net Income |
-36.12M
est: -63.71M (+43.3%)
|
-18.79M
est: -22.03M (+14.7%)
|
-37.94M
est: -34.53M (-9.9%)
|
-55.18M
est: -72.52M (+23.9%)
|
-38.18M
est: -22.07M (-73.0%)
|
-63.66M
-72.86M – -54.46M
-188.5% YoY
|
-63.44M
-193.11M – 96.55M
+0.3% YoY
|
24.35M
-90.56M – 140.87M
+138.4% YoY
|
119.42M
119.42M – 119.42M
+390.4% YoY
|
261.88M
261.88M – 261.88M
+119.3% YoY
|
| SGA |
11.26M
est: 1.67M (+575.5%)
|
14.06M
est: 4.10M (+242.7%)
|
14.41M
est: 782.7K (+1,741.2%)
|
14.06M
est: 637.2K (+2,106.2%)
|
17.77M
est: 178.74M (-90.1%)
|
3.80B
3.80B – 3.80B
+2,027.3% YoY
|
1.99B
1.99B – 1.99B
-47.7% YoY
|
7.63B
7.63B – 7.63B
+283.5% YoY
|
18.18B
18.18B – 18.18B
+138.4% YoY
|
31.40B
31.40B – 31.40B
+72.7% YoY
|
| EPS |
-1.26
est: -2.01 (+37.4%)
|
-0.10
est: -0.70 (+85.7%)
|
-1.31
est: -1.09 (-20.2%)
|
-1.74
est: -1.37 (-27.1%)
|
-0.72
est: -0.42 (-70.8%)
|
-1.26
-1.38 – -1.03
-197.8% YoY
|
-0.91
-3.65 – 1.82
+27.4% YoY
|
0.33
-1.71 – 2.66
+136.5% YoY
|
2.26
2.26 – 2.26
+578.5% YoY
|
4.95
4.95 – 4.95
+119.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-38.31M
OE per share TTM
-0.82
Owner's Yield
-7.89%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
3,857.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
38
Total invested
26.92M
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Paul B. Manning | 4.07M | 13.60% | 2.97M | 1.11M | 2.97M | 10.00 | IN | United States | 2022-02-14 | ↗ |
| 2 | 2 | 1.69M | 5.90% | — | 1.69M | — | 1.69M | PN | — | 2022-02-14 | ↗ |
| 3 | The Paul B. Manning Revocable Trust dated May 10, 2000 | 1.28M | 4.40% | 1.28M | — | 1.28M | 10.00 | OO | Virginia | 2022-02-14 | ↗ |
| 4 | BKB Growth Investments, LLC | 1.11M | 3.80% | 1.11M | — | 1.11M | 10.00 | OO | Delaware | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
38
-50 vs prev Q
New positions
10
Closed positions
55
Increased
26
Reduced
6
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | FMR LLC | 8.23M +914.0 (+0.0%) | 46.52M +4.5M (+10.8%) | 15.00% -0.990 pp | 0.00% +0.000 pp | USD7.01 -19.4% | 6 qtrs — |
| 2 | BLACKROCK, INC. | 2.86M +482.4K (+20.3%) | 16.17M +4.0M (+33.2%) | 5.21% +0.592 pp | 0.00% +0.000 pp | USD6.09 -7.2% | 6 qtrs — |
| 3 | ACORN CAPITAL ADVISORS, LLC | 2.58M +— (+0.0%) | 14.58M +1.4M (+10.8%) | 4.70% -0.311 pp | 4.94% -1.741 pp | USD7.83 -27.8% | 5 qtrs — |
| 4 | VANGUARD GROUP INC | 2.31M +297.9K (+14.8%) | 13.02M +2.8M (+27.2%) | 4.20% +0.301 pp | 0.00% +0.000 pp | USD6.67 -15.3% | 18 qtrs — |
| 5 | PORTOLAN CAPITAL MANAGEMENT, LLC | 1.70M +311.2K (+22.5%) | 9.58M +2.5M (+35.7%) | 3.09% +0.400 pp | 0.51% +0.131 pp | USD6.58 -14.1% | 5 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 977.5K +49.3K (+5.3%) | 5.52M +789.2K (+16.7%) | 1.78% -0.022 pp | 0.00% +0.000 pp | USD5.73 -1.4% | 18 qtrs — |
| 7 | STATE STREET CORP | 792.2K +103.5K (+15.0%) | 4.48M +963.3K (+27.4%) | 1.44% +0.106 pp | 0.00% +0.000 pp | USD6.39 -11.6% | 18 qtrs — |
| 8 | HALTER FERGUSON FINANCIAL INC. | 748.1K +50.1K (+7.2%) | 4.23M +666.7K (+18.7%) | 1.36% +0.007 pp | 0.93% +0.115 pp | USD7.43 -24.0% | 6 qtrs — |
| 9 | SANDS CAPITAL VENTURES, LLC | 405.8K +— (+0.0%) | 2.29M +223.2K (+10.8%) | 0.74% -0.049 pp | 0.44% -0.011 pp | USD10.84 -47.9% | 18 qtrs — |
| 10 | NORTHERN TRUST CORP | 295.4K -11.3K (-3.7%) | 1.67M +104.7K (+6.7%) | 0.54% -0.058 pp | 0.00% +0.000 pp | USD6.12 -7.7% | 17 qtrs — |
| 11 | CITADEL ADVISORS LLC | 226.4K -25.9K (-10.3%) | 1.28M -7.8K (-0.6%) | 0.41% -0.078 pp | 0.00% +0.000 pp | USD5.10 +10.8% | 6 qtrs — |
| 12 | TANAGER WEALTH MANAGEMENT LLP | 198.2K +— (+0.0%) | 1.12M +109.0K (+10.8%) | 0.36% -0.024 pp | 0.11% +0.006 pp | USD5.06 +11.7% | 3 qtrs — |
| 13 | MORGAN STANLEY | 134.0K +58.1K (+76.5%) | 757.3K +370.0K (+95.5%) | 0.24% +0.097 pp | 0.00% +0.000 pp | USD5.93 -4.7% | 7 qtrs — |
| 14 | JANE STREET GROUP, LLC | 132.4K +22.0K (+19.9%) | 748.1K +185.0K (+32.9%) | 0.24% +0.027 pp | 0.00% +0.000 pp | USD5.87 -3.7% | 5 qtrs — |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 121.0K +— (+0.0%) | 683.7K +66.6K (+10.8%) | 0.22% -0.015 pp | 0.00% +0.000 pp | USD5.86 -3.6% | 7 qtrs — |
| 16 | UBS GROUP AG | 104.3K +10.3K (+10.9%) | 589.5K +109.8K (+22.9%) | 0.19% +0.007 pp | 0.00% +0.000 pp | USD7.50 -24.7% | 18 qtrs — |
| 17 | TWO SIGMA INVESTMENTS, LP | 99.2K -36.9K (-27.1%) | 560.5K -133.7K (-19.3%) | 0.18% -0.084 pp | 0.00% 0.000 pp | USD5.06 +11.7% | 3 qtrs — |
| 18 | BANK OF NEW YORK MELLON CORP | 95.2K +639.0 (+0.7%) | 537.9K +55.6K (+11.5%) | 0.17% -0.010 pp | 0.00% +0.000 pp | USD5.75 -1.7% | 7 qtrs — |
| 19 | NUVEEN, LLC | 92.5K -117.2K (-55.9%) | 522.5K -546.8K (-51.1%) | 0.17% -0.239 pp | 0.00% 0.000 pp | USD5.30 +6.6% | 4 qtrs — |
| 20 | COMMONWEALTH EQUITY SERVICES, LLC | 82.3K +125.0 (+0.2%) | 465.3K +46.3K (+11.0%) | 0.15% -0.010 pp | 0.00% +0.000 pp | USD7.04 -19.7% | 5 qtrs — |
| 21 | COLONY GROUP, LLC | 81.8K +81.8K (+100.0%) | 462.3K +462.3K (+100.0%) | 0.15% +0.149 pp | 0.00% +0.001 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 22 | WELLS FARGO & COMPANY/MN | 73.9K +47.6K (+180.9%) | 417.5K +283.3K (+211.2%) | 0.13% +0.084 pp | 0.00% +0.000 pp | USD5.76 -1.9% | 13 qtrs — |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 73.0K -20.7K (-22.1%) | 412.5K -65.4K (-13.7%) | 0.13% -0.049 pp | 0.00% +0.000 pp | USD8.30 -31.9% | 7 qtrs — |
| 24 | BARCLAYS PLC | 69.3K +40.7K (+141.7%) | 391.8K +193.0K (+97.1%) | 0.13% +0.071 pp | 0.00% +0.000 pp | USD5.79 -2.4% | 7 qtrs — |
| 25 | ALLIANCEBERNSTEIN L.P. | 69.1K +— (+0.0%) | 390.5K +38.0K (+10.8%) | 0.13% -0.008 pp | 0.00% +0.000 pp | USD5.25 +7.6% | 7 qtrs — |
| 26 | — | 66.8K +66.8K (+100.0%) | 377.1K +377.1K (+100.0%) | 0.12% +0.122 pp | 0.13% +0.131 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 27 | GOLDMAN SACHS GROUP INC | 65.1K +29.1K (+80.7%) | 367.7K +184.0K (+100.2%) | 0.12% +0.049 pp | 0.00% +0.000 pp | USD6.33 -10.7% | 7 qtrs — |
| 28 | BIRCHVIEW CAPITAL, LP | 60.0K +— (+0.0%) | 339.0K +33.0K (+10.8%) | 0.11% -0.007 pp | 0.20% -0.033 pp | USD8.68 -34.9% | 5 qtrs — |
| 29 | HB WEALTH MANAGEMENT, LLC | 58.3K +— (+0.0%) | 329.6K +32.1K (+10.8%) | 0.11% -0.007 pp | 0.00% +0.000 pp | USD5.10 +10.8% | 6 qtrs — |
| 30 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55.1K +— (+0.0%) | 311.3K +30.3K (+10.8%) | 0.10% -0.007 pp | 0.01% +0.001 pp | USD5.06 +11.7% | 16 qtrs — |
| 31 | LIDO ADVISORS, LLC | 60.2K +— (+0.0%) | 307.0K +— (+0.0%) | 0.11% -0.007 pp | 0.00% +0.000 pp | USD5.10 +10.8% | 2 qtrs — |
| 32 | STATE OF WISCONSIN INVESTMENT BOARD | 52.1K -1.9K (-3.5%) | 294.6K +19.0K (+6.9%) | 0.10% -0.010 pp | 0.00% +0.000 pp | USD5.10 +10.8% | 2 qtrs — |
| 33 | BANK OF AMERICA CORP /DE/ | 51.3K +3.6K (+7.6%) | 289.7K +46.8K (+19.2%) | 0.09% +0.001 pp | 0.00% +0.000 pp | USD6.43 -12.1% | 9 qtrs — |
| 34 | RHUMBLINE ADVISERS | 51.0K -2.6K (-4.9%) | 288.2K +14.6K (+5.3%) | 0.09% -0.011 pp | 0.00% +0.000 pp | USD5.90 -4.2% | 7 qtrs — |
| 35 | ALPS ADVISORS INC | 45.1K +18.8K (+71.5%) | 254.7K +120.7K (+90.0%) | 0.08% +0.031 pp | 0.00% +0.001 pp | USD5.31 +6.4% | 3 qtrs — |
| 36 | MONETA GROUP INVESTMENT ADVISORS LLC | 42.5K +2.0K (+4.9%) | 240.2K +33.6K (+16.3%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD5.63 +0.4% | 4 qtrs — |
| 37 | MARTINGALE ASSET MANAGEMENT L P | 37.5K +37.5K (+100.0%) | 212.0K +212.0K (+100.0%) | 0.07% +0.068 pp | 0.01% +0.005 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 38 | RAYMOND JAMES FINANCIAL INC | 33.0K +10.8K (+48.9%) | 186.5K +73.4K (+64.9%) | 0.06% +0.017 pp | 0.00% +0.000 pp | USD5.65 +0.0% | 4 qtrs — |
| 39 | LPL FINANCIAL LLC | 28.7K +7.3K (+33.9%) | 161.9K +52.7K (+48.3%) | 0.05% +0.011 pp | 0.00% +0.000 pp | USD5.21 +8.4% | 5 qtrs — |
| 40 | DEUTSCHE BANK AG\ | 28.4K +1.7K (+6.4%) | 160.3K +24.4K (+17.9%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD7.84 -27.9% | 7 qtrs — |
| 41 | JANNEY MONTGOMERY SCOTT LLC | 27.1K -3.3K (-10.9%) | 153.0K -2.0K (-1.3%) | 0.05% -0.010 pp | 0.00% +0.000 pp | USD5.70 -0.9% | 7 qtrs — |
| 42 | VIRTU FINANCIAL LLC | 26.8K +26.8K (+100.0%) | 152.0K +152.0K (+100.0%) | 0.05% +0.049 pp | 0.01% +0.006 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 43 | PRICE T ROWE ASSOCIATES INC /MD/ | 25.8K +6.2K (+31.4%) | 146.0K +45.0K (+44.6%) | 0.05% +0.009 pp | 0.00% +0.000 pp | USD5.48 +3.1% | 4 qtrs — |
| 44 | KRILOGY FINANCIAL LLC | 24.0K +24.0K (+100.0%) | 144.2K +144.2K (+100.0%) | 0.04% +0.044 pp | 0.00% +0.005 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 45 | XTX TOPCO LTD | 23.8K +23.8K (+100.0%) | 134.3K +134.3K (+100.0%) | 0.04% +0.043 pp | 0.00% +0.004 pp | USD5.65 +0.0% | 3 qtrs — |
| 46 | STRATOS WEALTH ADVISORS, LLC | 23.0K +— (+0.0%) | 130.0K +12.7K (+10.8%) | 0.04% -0.003 pp | 0.01% +0.001 pp | USD5.65 +0.0% | 4 qtrs — |
| 47 | JPMORGAN CHASE & CO | 21.6K +3.8K (+21.3%) | 122.2K +31.2K (+34.3%) | 0.04% +0.005 pp | 0.00% +0.000 pp | USD5.92 -4.6% | 11 qtrs — |
| 48 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 20.0K +538.0 (+2.8%) | 113.0K +13.7K (+13.8%) | 0.04% -0.001 pp | 0.00% +0.000 pp | USD6.33 -10.7% | 6 qtrs — |
| 49 | SQUAREPOINT OPS LLC | 19.7K -11.2K (-36.3%) | 111.5K -46.4K (-29.4%) | 0.04% -0.024 pp | 0.00% +0.000 pp | USD6.10 -7.4% | 7 qtrs — |
| 50 | METLIFE INVESTMENT MANAGEMENT, LLC | 19.4K +4.0K (+25.5%) | 109.9K +30.9K (+39.1%) | 0.04% +0.005 pp | 0.00% +0.000 pp | USD6.08 -7.1% | 6 qtrs — |
| 51 | INTECH INVESTMENT MANAGEMENT LLC | 17.8K -2.7K (-13.2%) | 100.7K -4.1K (-3.9%) | 0.03% -0.007 pp | 0.00% +0.000 pp | USD5.65 +0.0% | 4 qtrs — |
| 52 | BOREAL CAPITAL MANAGEMENT LLC | 16.0K +— (+0.0%) | 90.4K +8.8K (+10.8%) | 0.03% -0.002 pp | 0.08% +0.005 pp | USD5.06 +11.7% | 3 qtrs — |
| 53 | INVESCO LTD. | 15.0K +3.4K (+29.0%) | 85.0K +25.5K (+42.9%) | 0.03% +0.005 pp | 0.00% +0.000 pp | USD5.60 +0.9% | 4 qtrs — |
| 54 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 13.6K -121.0 (-0.9%) | 76.9K +6.9K (+9.8%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD5.06 +11.7% | 3 qtrs — |
| 55 | TAYLOR FINANCIAL GROUP, INC. | 13.6K +— (+0.0%) | 76.8K +7.5K (+10.8%) | 0.02% -0.002 pp | 0.05% +0.005 pp | USD5.50 +2.7% | 4 qtrs — |
| 56 | QUEST PARTNERS LLC | 11.9K +— (+0.0%) | 67.5K +6.6K (+10.8%) | 0.02% -0.001 pp | 0.00% 0.000 pp | USD5.60 +0.9% | 4 qtrs — |
| 57 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 11.2K +— (+0.0%) | 63.3K +6.2K (+10.8%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD6.83 -17.3% | 5 qtrs — |
| 58 | PROSHARE ADVISORS LLC | 10.4K +10.4K (+100.0%) | 58.9K +58.9K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 59 | BNP PARIBAS ARBITRAGE, SNC | 9.9K +2.0K (+25.7%) | 56.1K +15.8K (+39.3%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD5.70 -0.9% | 5 qtrs — |
| 60 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 8.9K +8.9K (+100.0%) | 50.5K +50.5K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.004 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 61 | GROUP ONE TRADING, L.P. | 8.9K +8.9K (+100.0%) | 50.3K +50.3K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 62 | ADVISOR GROUP HOLDINGS, INC. | 6.5K -8.4K (-56.4%) | 36.6K -49.4K (-57.4%) | 0.01% -0.017 pp | 0.00% 0.000 pp | USD6.07 -6.9% | 7 qtrs — |
| 63 | LEGAL & GENERAL GROUP PLC | 4.2K +— (+0.0%) | 23.9K +2.3K (+10.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD5.80 -2.6% | 7 qtrs — |
| 64 | RUSSELL INVESTMENTS GROUP, LTD. | 4.2K +905.0 (+27.8%) | 23.5K +6.9K (+41.6%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD5.22 +8.2% | 6 qtrs — |
| 65 | AMERITAS INVESTMENT PARTNERS, INC. | 4.0K +— (+0.0%) | 22.7K +2.2K (+10.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD5.66 -0.2% | 7 qtrs — |
| 66 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2.7K +243.0 (+9.9%) | 15.2K +2.7K (+21.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.01 -6.0% | 7 qtrs — |
| 67 | CITIGROUP INC | 2.7K +963.0 (+56.3%) | 15.1K +6.4K (+73.1%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD6.54 -13.6% | 7 qtrs — |
| 68 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.7K +2.7K (+100.0%) | 15.1K +15.1K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 69 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.9K -3.8K (-66.6%) | 10.6K -18.1K (-63.0%) | 0.00% -0.008 pp | 0.00% -0.001 pp | USD5.06 +11.7% | 15 qtrs — |
| 70 | ROYAL BANK OF CANADA | 1.8K +851.0 (+85.6%) | 10.0K +5.0K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD5.41 +4.4% | 7 qtrs — |
| 71 | NEW YORK STATE COMMON RETIREMENT FUND | 1.7K +— (+0.0%) | 9.6K +935.0 (+10.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD6.30 -10.3% | 7 qtrs — |
| 72 | CLOSE ASSET MANAGEMENT LTD | 1.4K +— (+0.0%) | 8.0K +1.0K (+14.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.06 +11.7% | 3 qtrs — |
| 73 | AMALGAMATED BANK | 1.4K +397.0 (+40.5%) | 8.0K +3.0K (+60.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD5.97 -5.4% | 7 qtrs — |
| 74 | GF FUND MANAGEMENT CO. LTD. | 1.1K +1.1K (+100.0%) | 6.1K +6.1K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD5.65 +0.0% | 1 qtrs NEW |
| 75 | JONES FINANCIAL COMPANIES LLLP | 1.0K -310.0 (-23.3%) | 5.8K -1.6K (-21.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD5.29 +6.8% | 4 qtrs — |
| 76 | OPTIVER HOLDING B.V. | 656.00 +— (+0.0%) | 3.7K +360.0 (+10.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.10 +10.8% | 2 qtrs — |
| 77 | STERLING CAPITAL MANAGEMENT LLC | 510.00 +156.0 (+44.1%) | 2.9K +1.1K (+59.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.35 +5.6% | 6 qtrs — |
| 78 | GAMMA INVESTING LLC | 295.00 +96.0 (+48.2%) | 1.7K +652.0 (+64.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.42 +4.2% | 6 qtrs — |
| 79 | NISA INVESTMENT ADVISORS, LLC | 48.00 +— (+0.0%) | 271.00 +26.0 (+10.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.19 -8.7% | 6 qtrs — |
| 80 | SBI SECURITIES CO., LTD. | 20.00 -1.0 (-4.8%) | 113.00 +6.0 (+5.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.70 -15.7% | 5 qtrs — |
| 81 | SUNBELT SECURITIES, INC. | 16.00 -11.0 (-40.7%) | 90.00 -48.0 (-34.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.06 +11.7% | 2 qtrs — |
| 82 | PNC FINANCIAL SERVICES GROUP, INC. | 5.00 -59.0 (-92.2%) | 28.00 -298.0 (-91.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.00 +13.0% | 2 qtrs — |
| 83 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 1.00 +1.0 (+100.0%) | 6.00 +6.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.00 +13.0% | 5 qtrs — |
| 84 | ENTRYPOINT CAPITAL, LLC | — -18.7K (-100.0%) | — -95.4K (-100.0%) | 0.00% -0.036 pp | 0.00% -0.037 pp | USD— | 4 qtrs SOLD |
| 85 | QUADRATURE CAPITAL LTD | — -13.8K (-100.0%) | — -70.5K (-100.0%) | 0.00% -0.027 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 86 | QUARRY LP | — -4.2K (-100.0%) | — -21.4K (-100.0%) | 0.00% -0.008 pp | 0.00% -0.005 pp | USD— | 2 qtrs SOLD |
| 87 | MILLENNIUM MANAGEMENT LLC | — -136.7K (-100.0%) | — -697.0K (-100.0%) | 0.00% -0.265 pp | 0.00% 0.000 pp | USD— | 7 qtrs SOLD |
| 88 | MARSHALL WACE, LLP | — -103.8K (-100.0%) | — -529.6K (-100.0%) | 0.00% -0.202 pp | 0.00% -0.001 pp | USD— | 4 qtrs SOLD |
| 89 | SRS CAPITAL ADVISORS, INC. | — -54.0 (-100.0%) | — -275.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 90 | KOVITZ INVESTMENT GROUP PARTNERS, LLC | — -79.3K (-100.0%) | — -404.5K (-100.0%) | 0.00% -0.154 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 91 | BALYASNY ASSET MANAGEMENT L.P. | — -49.5K (-100.0%) | — -252.4K (-100.0%) | 0.00% -0.096 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 92 | CWM, LLC | — -196.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 93 | WELLINGTON MANAGEMENT GROUP LLP | — -137.9K (-100.0%) | — -703.2K (-100.0%) | 0.00% -0.268 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 94 | EVERSOURCE WEALTH ADVISORS, LLC | — -86.0 (-100.0%) | — -439.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 64 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.68% | 392.8K | 0.65% |
| 2 | ALPS Medical Breakthroughs ETF SBIO | 0.36% | 759.3K | 0.50% |
| 3 | Global X - S&P Biotech ETF CURE.AX | 0.18% | 64.1K | 0.45% |
| 4 | State Street SPDR S&P Biotech ETF XBI | 0.18% | 19.26M | 0.35% |
| 5 | iShares Micro-Cap ETF IWC | 0.14% | 2.01M | 0.60% |
| 6 | State Street SPDR S&P Kensho New Economies Composite ETF KOMP | 0.09% | 2.50M | 0.20% |
| 7 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.05% | 35.9K | 0.35% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.05% | 536.8K | 0.35% |
| 9 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.05% | 221.2K | 0.40% |
| 10 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.05% | 35.7K | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
9
Sells
0
Shares acquired
1.94M
Shares disposed
—
Cash buys
1.00
Cash sales
—
Net activity
+1,942,150
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (Right to Buy) | 2,795 | 4.90 | 13.7K | 2,795 | D | ↗ |
| 2026-03-31 | Manning Paul B | Director | A-Award | A | Stock Option (Right to Buy) | 4,618 | 4.90 | 22.6K | 4,618 | D | ↗ |
| 2026-03-31 | Loggia Nicoletta | Director | A-Award | A | Stock Option (Right to Buy) | 779 | 4.90 | 3.8K | 779 | D | ↗ |
| 2026-02-23 | Manning Paul B | Director | P-Purchase | A | Common Stock | 550,458 | 5.45 | 3.00M | 2,763,527 | I | ↗ |
| 2026-01-26 | Tyagarajan Seshu | Officer | A-Award | A | Stock Option (Right to Buy) | 154,000 | 6.01 | 925.5K | 154,000 | D | ↗ |
| 2026-01-26 | Tak Paul Peter | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 629,000 | 6.01 | 3.78M | 629,000 | D | ↗ |
| 2026-01-26 | Schoch Charles | Officer | A-Award | A | Stock Option (Right to Buy) | 232,000 | 6.01 | 1.39M | 232,000 | D | ↗ |
| 2026-01-26 | Nichols William Garrett | Officer | A-Award | A | Stock Option (Right to Buy) | 136,500 | 6.01 | 820.4K | 136,500 | D | ↗ |
| 2026-01-26 | Barone Francesca | Officer | A-Award | A | Stock Option (Right to Buy) | 232,000 | 6.01 | 1.39M | 232,000 | D | ↗ |
| 2025-07-28 | Nichols William Garrett | Officer | M-Exempt | A | Common Stock | 937 | 1.29 | 1.2K | 53,430 | D | ↗ |
| 2025-06-30 | Nichols William Garrett | Officer | M-Exempt | D | Stock Option (Right to Buy) | 781 | 1.29 | 1.0K | 30,314 | D | ↗ |
| 2025-06-25 | Tyagarajan Seshu | Officer | A-Award | A | Common Stock | 5,353 | 4.67 | 25.0K | 90,865 | D | ↗ |
| 2025-06-25 | Tak Paul Peter | Director / Officer | A-Award | A | Common Stock | 42,826 | 4.67 | 200.0K | 268,566 | D | ↗ |
| 2025-06-25 | Schoch Charles | Officer | A-Award | A | Common Stock | 5,353 | 4.67 | 25.0K | 43,391 | D | ↗ |
| 2025-06-25 | PAPA JOSEPH C | Director | A-Award | A | Common Stock | 64,239 | 4.67 | 300.0K | 64,239 | I | ↗ |
| 2025-06-25 | Nabel Gary J. | Director | A-Award | A | Common Stock | 5,353 | 4.67 | 25.0K | 5,353 | D | ↗ |
| 2025-06-25 | Martell Christopher | Director | A-Award | A | Common Stock | 111,349 | 4.67 | 520.0K | 111,349 | I | ↗ |
| 2025-06-25 | Manning Paul B | Director | A-Award | A | Common Stock | 1,070,663 | 4.67 | 5.00M | 2,213,069 | I | ↗ |
| 2025-06-25 | Loggia Nicoletta | Director | A-Award | A | Common Stock | 2,141 | 4.67 | 10.0K | 2,141 | D | ↗ |
| 2025-06-25 | Barone Francesca | Officer | A-Award | A | Common Stock | 4,282 | 4.67 | 20.0K | 100,809 | D | ↗ |
| 2025-06-20 | Schoch Charles | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 4.75 | 237.5K | 50,000 | D | ↗ |
| 2025-06-17 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Nguyen Diem | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Nabel Gary J. | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Martell Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Manning Paul B | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Loggia Nicoletta | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Gaeta Renee | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-17 | Benz Edward J. JR | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 4.94 | 70.3K | 14,240 | D | ↗ |
| 2025-06-04 | Radhakrishnan Maha | Director | A-Award | A | Stock Option (Right to Buy) | 28,480 | 5.60 | 159.5K | 28,480 | D | ↗ |
| 2025-03-19 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 400 | 9.00 | 3.6K | 225,740 | D | ↗ |
| 2025-03-18 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 25,772 | 8.77 | 226.0K | 226,140 | D | ↗ |
| 2025-03-18 | Nichols William Garrett | Officer | M-Exempt | A | Common Stock | 4,584 | 3.75 | 17.2K | 83,904 | D | ↗ |
| 2025-03-18 | Barone Francesca | Officer | M-Exempt | A | Common Stock | 18,000 | 1.55 | 27.9K | 128,673 | D | ↗ |
| 2025-03-17 | Tyagarajan Seshu | Officer | M-Exempt | D | Stock Option (Right to Buy) | 20,000 | 1.29 | 25.8K | 70,000 | D | ↗ |
| 2025-03-17 | Schoch Charles | Officer | S-Sale | D | Common Stock | 5,000 | 8.83 | 44.2K | 38,038 | D | ↗ |
| 2025-02-21 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 10,583 | 12.02 | 127.2K | 162,929 | D | ↗ |
| 2025-02-12 | Tyagarajan Seshu | Officer | A-Award | A | Stock Option (Right to Buy) | 65,000 | 8.55 | 555.8K | 65,000 | D | ↗ |
| 2025-02-12 | Tak Paul Peter | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 525,000 | 8.55 | 4.49M | 525,000 | D | ↗ |
| 2025-02-12 | Schoch Charles | Officer | A-Award | A | Stock Option (Right to Buy) | 83,000 | 8.55 | 709.7K | 83,000 | D | ↗ |
| 2025-02-12 | Nichols William Garrett | Officer | A-Award | A | Stock Option (Right to Buy) | 107,250 | 8.55 | 917.0K | 107,250 | D | ↗ |
| 2025-02-12 | Barone Francesca | Officer | A-Award | A | Stock Option (Right to Buy) | 115,000 | 8.55 | 983.3K | 115,000 | D | ↗ |
| 2025-02-10 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 31,335 | 8.61 | 269.8K | 60,000 | D | ↗ |
| 2025-01-15 | Tyagarajan Seshu | Officer | S-Sale | D | Common Stock | 14,322 | 7.23 | 103.5K | 96,790 | D | ↗ |
| 2025-01-15 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 21,704 | 7.23 | 156.8K | 251,912 | D | ↗ |
| 2025-01-15 | Schoch Charles | Officer | S-Sale | D | Common Stock | 9,511 | 7.23 | 68.7K | 43,038 | D | ↗ |
| 2025-01-15 | Nichols William Garrett | Officer | S-Sale | D | Common Stock | 10,428 | 7.23 | 75.3K | 79,320 | D | ↗ |
| 2025-01-15 | Barone Francesca | Officer | S-Sale | D | Common Stock | 13,534 | 7.23 | 97.8K | 110,673 | D | ↗ |
| 2025-01-08 | Tyagarajan Seshu | Officer | S-Sale | D | Common Stock | 14,545 | 8.22 | 119.5K | 111,112 | D | ↗ |
| 2025-01-08 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 21,172 | 8.22 | 174.0K | 273,616 | D | ↗ |
| 2025-01-08 | Schoch Charles | Officer | S-Sale | D | Common Stock | 9,971 | 8.22 | 81.9K | 52,549 | D | ↗ |
| 2025-01-08 | Nichols William Garrett | Officer | S-Sale | D | Common Stock | 10,799 | 8.22 | 88.7K | 89,748 | D | ↗ |
| 2025-01-08 | Barone Francesca | Officer | S-Sale | D | Common Stock | 13,673 | 8.22 | 112.4K | 124,207 | D | ↗ |
| 2024-12-27 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 50,000 | 8.85 | 442.5K | 173,512 | D | ↗ |
| 2024-12-26 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 50,000 | 9.01 | 450.5K | 223,512 | D | ↗ |
| 2024-12-24 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | A | CADL | 50,000 | 8.82 | 441.0K | 273,512 | D | ↗ |
| 2024-12-23 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 50,000 | 8.52 | 426.0K | 323,512 | D | ↗ |
| 2024-12-20 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 100,000 | 9.00 | 900.0K | 373,512 | D | ↗ |
| 2024-12-16 | Manning Paul B | Director | P-Purchase | A | Common Stock | 750,000 | 6.00 | 4.50M | 1,303,752 | I | ↗ |
| 2024-12-12 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 200,000 | 10.04 | 2.01M | 473,512 | D | ↗ |
| 2024-12-11 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 200,000 | 8.53 | 1.71M | 631,443 | I | ↗ |
| 2024-12-06 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 20,000 | 5.23 | 104.6K | 91,335 | D | ↗ |
| 2024-12-05 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 20,000 | 4.79 | 95.8K | 111,335 | D | ↗ |
| 2024-12-04 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 20,000 | 4.46 | 89.2K | 131,335 | D | ↗ |
| 2024-11-29 | Tyagarajan Seshu | Officer | S-Sale | D | Common Stock | 20,392 | 4.56 | 92.9K | 125,657 | D | ↗ |
| 2024-11-29 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 48,847 | 4.56 | 222.5K | 294,788 | D | ↗ |
| 2024-11-29 | Nichols William Garrett | Officer | S-Sale | D | Common Stock | 13,935 | 4.56 | 63.5K | 100,547 | D | ↗ |
| 2024-11-29 | Barone Francesca | Officer | S-Sale | D | Common Stock | 22,081 | 4.56 | 100.6K | 137,880 | D | ↗ |
| 2024-11-25 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 20,000 | 4.97 | 99.4K | 151,335 | D | ↗ |
| 2024-11-21 | Tak Paul Peter | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,900 | 1.55 | 20.0K | 1,763,968 | D | ↗ |
| 2024-11-08 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 7,500 | 4.92 | 36.9K | 831,443 | I | ↗ |
| 2024-11-07 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 7,500 | 5.19 | 38.9K | 881,012 | D | ↗ |
| 2024-11-06 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 7,500 | 5.33 | 40.0K | 846,443 | I | ↗ |
| 2024-11-01 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 7,500 | 5.27 | 39.5K | 896,012 | D | ↗ |
| 2024-10-31 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 7,500 | 5.30 | 39.8K | 903,512 | D | ↗ |
| 2024-10-30 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 6,000 | 5.38 | 32.3K | 911,012 | D | ↗ |
| 2024-10-28 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 11,711 | 5.58 | 65.3K | 888,532 | D | ↗ |
| 2024-10-25 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 1,597 | 5.80 | 9.3K | 900,243 | D | ↗ |
| 2024-10-24 | Aguilar-Cordova Estuardo | 10% Owner | D-Return | D | CADL | 16,427 | 5.53 | 90.8K | 903,034 | D | ↗ |
| 2024-10-15 | Aguilar-Cordova Estuardo | 10% Owner | S-Sale | D | CADL | 10,412 | 6.03 | 62.8K | 919,461 | D | ↗ |
| 2024-10-14 | Aguilar-Cordova Estuardo | 10% Owner | S-Sale | D | CADL | 15,000 | 6.02 | 90.3K | 929,873 | D | ↗ |
| 2024-10-11 | Aguilar-Cordova Estuardo | 10% Owner | S-Sale | D | CADL | 15,000 | 6.05 | 90.8K | 944,873 | D | ↗ |
| 2024-10-03 | Aguilar-Cordova Estuardo | 10% Owner | S-Sale | D | CADL | 1,800 | 6.85 | 12.3K | 959,873 | D | ↗ |
| 2024-10-02 | Aguilar-Cordova Estuardo | 10% Owner | S-Sale | D | CADL | 26,988 | 6.92 | 186.8K | 961,673 | D | ↗ |
| 2024-10-01 | Aguilar-Cordova Estuardo | 10% Owner | S-Sale | A | CADL | 6,214 | 7.01 | 43.6K | 988,661 | D | ↗ |
| 2024-07-17 | Tyagarajan Seshu | Officer | S-Sale | D | Common Stock | 14,851 | 6.47 | 96.1K | 146,049 | — | ↗ |
| 2024-07-17 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 22,528 | 6.47 | 145.8K | 330,735 | — | ↗ |
| 2024-07-17 | Schoch Charles | Officer | S-Sale | D | Common Stock | 9,884 | 6.47 | 64.0K | 62,520 | — | ↗ |
| 2024-07-17 | Nichols William Garrett | Officer | S-Sale | D | Common Stock | 10,875 | 6.47 | 70.4K | 114,482 | — | ↗ |
| 2024-07-17 | Barone Francesca | Officer | S-Sale | D | Common Stock | 14,051 | 6.47 | 90.9K | 159,961 | — | ↗ |
| 2024-07-11 | Tyagarajan Seshu | Officer | S-Sale | D | Common Stock | 13,330 | 5.97 | 79.6K | 160,900 | — | ↗ |
| 2024-07-11 | Tak Paul Peter | Director / Officer | S-Sale | D | Common Stock | 20,293 | 5.97 | 121.2K | 353,263 | — | ↗ |
| 2024-07-11 | Schoch Charles | Officer | S-Sale | D | Common Stock | 8,897 | 5.97 | 53.1K | 72,404 | — | ↗ |
| 2024-07-11 | Nichols William Garrett | Officer | S-Sale | D | Common Stock | 9,769 | 5.97 | 58.4K | 125,357 | — | ↗ |
| 2024-07-11 | Barone Francesca | Officer | S-Sale | D | Common Stock | 12,645 | 5.97 | 75.5K | 174,012 | — | ↗ |
| 2024-06-26 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Nguyen Diem | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Nabel Gary J. | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Martell Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Manning Paul B | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Loggia Nicoletta | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Gaeta Renee | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-06-26 | Benz Edward J. JR | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 5.71 | 81.3K | 14,240 | — | ↗ |
| 2024-01-12 | Schoch Charles | Officer | — | D | Common Stock | 0 | 0.00 | — | 79,301 | — | ↗ |
| 2023-11-28 | Tyagarajan Seshu | Officer | F-InKind | D | Common Stock | 17,328 | 0.90 | 15.6K | 174,230 | — | ↗ |
| 2023-11-28 | Tak Paul Peter | Director / Officer | F-InKind | D | Common Stock | 43,443 | 0.90 | 39.1K | 373,556 | — | ↗ |
| 2023-11-28 | Nichols William Garrett | Officer | F-InKind | D | Common Stock | 12,175 | 0.90 | 11.0K | 135,126 | — | ↗ |
| 2023-11-28 | Barone Francesca | Officer | F-InKind | D | Common Stock | 19,748 | 0.90 | 17.8K | 186,657 | — | ↗ |
| 2023-11-28 | Amello Jason | Officer | F-InKind | D | Common Stock | 20,153 | 0.90 | 18.1K | 202,009 | — | ↗ |
| 2023-11-26 | Tyagarajan Seshu | Officer | A-Award | A | Common Stock | 104,516 | 0.00 | — | 191,558 | — | ↗ |
| 2023-11-26 | Tak Paul Peter | Director / Officer | A-Award | A | Common Stock | 180,108 | 0.00 | — | 416,999 | — | ↗ |
| 2023-11-26 | Nichols William Garrett | Officer | A-Award | A | Common Stock | 88,822 | 0.00 | — | 147,301 | — | ↗ |
| 2023-11-26 | Barone Francesca | Officer | A-Award | A | Common Stock | 112,790 | 0.00 | — | 206,405 | — | ↗ |
| 2023-11-26 | Amello Jason | Officer | A-Award | A | Common Stock | 125,717 | 0.00 | — | 222,162 | — | ↗ |
| 2023-06-28 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Nguyen Diem | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Nabel Gary J. | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Martell Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Manning Paul B | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Gaeta Renee | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Benz Edward J. JR | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-28 | Aguilar-Cordova Estuardo | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 1.22 | 17.4K | 14,240 | — | ↗ |
| 2023-06-07 | Loggia Nicoletta | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-28 | Tyagarajan Seshu | Officer | A-Award | A | Stock Option (Right to Buy) | 90,000 | 1.29 | 116.1K | 90,000 | — | ↗ |
| 2023-04-28 | Tak Paul Peter | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 180,000 | 1.29 | 232.2K | 180,000 | — | ↗ |
| 2023-04-28 | Nichols William Garrett | Officer | A-Award | A | Stock Option (Right to Buy) | 45,000 | 1.29 | 58.1K | 45,000 | — | ↗ |
| 2023-04-28 | Barone Francesca | Officer | A-Award | A | Stock Option (Right to Biuy) | 90,000 | 1.29 | 116.1K | 90,000 | — | ↗ |
| 2023-04-28 | Amello Jason | Officer | A-Award | A | Stock Option (Right to Buy) | 90,000 | 1.29 | 116.1K | 90,000 | — | ↗ |
| 2022-12-09 | Tyagarajan Seshu | Officer | P-Purchase | A | Common Stock | 10,358 | 1.93 | 20.0K | 13,358 | — | ↗ |
| 2022-12-09 | Tak Paul Peter | Officer | P-Purchase | A | Common Stock | 12,935 | 1.92 | 24.8K | 40,985 | — | ↗ |
| 2022-12-09 | PAPA JOSEPH C | Director | P-Purchase | A | Common Stock | 35,018 | 1.94 | 67.9K | 38,032 | — | ↗ |
| 2022-12-09 | Martell Christopher | Director | P-Purchase | A | Common Stock | 23,950 | 1.92 | 46.0K | 152,000 | D | ↗ |
| 2022-12-09 | Amello Jason | Officer | P-Purchase | A | Common Stock | 2,468 | 1.93 | 4.8K | 5,568 | — | ↗ |
| 2022-12-08 | Tyagarajan Seshu | Officer | P-Purchase | A | Common Stock | 3,000 | 1.69 | 5.1K | 3,000 | — | ↗ |
| 2022-12-08 | Tak Paul Peter | Officer | P-Purchase | A | Common Stock | 3,050 | 1.70 | 5.2K | 28,050 | — | ↗ |
| 2022-12-08 | PAPA JOSEPH C | Director | P-Purchase | A | Common Stock | 3,014 | 1.70 | 5.1K | 3,014 | — | ↗ |
| 2022-12-08 | Martell Christopher | Director | P-Purchase | A | Common Stock | 3,050 | 1.68 | 5.1K | 128,050 | D | ↗ |
| 2022-12-08 | Barone Francesca | Officer | P-Purchase | A | Common Stock | 1,238 | 1.61 | 2.0K | 2,738 | — | ↗ |
| 2022-12-08 | Amello Jason | Officer | P-Purchase | A | Common Stock | 3,100 | 1.69 | 5.2K | 3,100 | — | ↗ |
| 2022-11-28 | Tyagarajan Seshu | Officer | A-Award | A | Common Stock | 73,684 | 0.00 | — | 73,684 | — | ↗ |
| 2022-11-28 | Tak Paul Peter | Officer | A-Award | A | Common Stock | 195,906 | 0.00 | — | 220,906 | — | ↗ |
| 2022-11-28 | Nichols William Garrett | Officer | A-Award | A | Common Stock | 58,479 | 0.00 | — | 58,479 | — | ↗ |
| 2022-11-28 | Barone Francesca | Officer | A-Award | A | Common Stock | 90,877 | 0.00 | — | 92,377 | — | ↗ |
| 2022-11-28 | Amello Jason | Officer | A-Award | A | Common Stock | 90,877 | 0.00 | — | 90,877 | — | ↗ |
| 2022-10-13 | Nguyen Diem | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 0.00 | — | 14,240 | — | ↗ |
| 2022-10-13 | Martell Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 0.00 | — | 14,240 | — | ↗ |
| 2022-10-13 | Manning Paul B | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 0.00 | — | 14,240 | — | ↗ |
| 2022-10-13 | Benz Edward J. JR | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 0.00 | — | 14,240 | — | ↗ |
| 2022-10-13 | Aguilar-Cordova Estuardo | Director | A-Award | A | Stock Option (Right to Buy) | 14,240 | 0.00 | — | 14,240 | — | ↗ |
| 2022-09-21 | Amello Jason | Officer | A-Award | A | Stock Option (Right to Buy) | 230,000 | 3.21 | 738.3K | 230,000 | — | ↗ |
| 2022-09-12 | Nichols William Garrett | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-08 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (Right to Buy) | 28,480 | 0.00 | — | 28,480 | — | ↗ |
| 2022-08-08 | Nabel Gary J. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-08 | Gaeta Renee | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-06 | Aguilar-Cordova Estuardo | Director | F-InKind | D | Common Stock | 54,074 | 3.65 | 197.4K | 1,097,032 | — | ↗ |
| 2022-05-06 | Aguilar Laura K. | Director | F-InKind | D | Common Stock | 68,534 | 3.65 | 250.1K | 1,033,840 | — | ↗ |
| 2022-04-14 | Tyagarajan Seshu | Officer | A-Award | A | Stock Option (Right to Buy) | 120,000 | 0.00 | — | 120,000 | — | ↗ |
| 2022-04-11 | Stewart Susan B. | Officer | A-Award | A | Stock Option (Right to Buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-02-28 | Tak Paul Peter | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 330,000 | 4.12 | 1.36M | 330,000 | — | ↗ |
| 2022-02-28 | Canepa John J | Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 4.12 | 453.2K | 110,000 | — | ↗ |
| 2022-02-28 | Barone Francesca | Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 4.12 | 453.2K | 110,000 | — | ↗ |
| 2022-02-03 | Barone Francesca | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 4.06 | 162.4K | 40,000 | — | ↗ |
| 2021-12-31 | Manning Paul B | Director / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,681,000 | — | ↗ |
| 2021-07-29 | Tak Paul Peter | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 8.00 | 200.0K | 25,000 | — | ↗ |
| 2021-07-29 | Nguyen Diem | Director | P-Purchase | A | Common Stock | 10,000 | 8.00 | 80.0K | 10,000 | — | ↗ |
| 2021-07-29 | Martell Christopher | Director | C-Conversion | D | Series B Preferred Stock | 696,851 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Manning Paul B | Director | C-Conversion | D | Series B Preferred Stock | 1,361,069 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Canepa John J | Officer | P-Purchase | A | Common Stock | 10,125 | 8.00 | 81.0K | 10,125 | — | ↗ |
| 2021-07-29 | Caffo Nathan | Officer | P-Purchase | A | Common Stock | 6,000 | 8.00 | 48.0K | 6,000 | — | ↗ |
| 2021-07-29 | Aguilar-Cordova Estuardo | Director / Officer | C-Conversion | A | Common Stock | 162,137 | 0.00 | — | 1,015,923 | — | ↗ |
| 2021-07-29 | Aguilar Laura K. | Officer | C-Conversion | D | Series B Preferred Stock | 137,881 | 0.00 | — | 0 | — | ↗ |
| 2021-07-27 | Manning Paul B | Director | P-Purchase | A | Common Stock | 36,000 | 7.36 | 264.8K | 36,000 | — | ↗ |
| 2021-07-26 | Tak Paul Peter | Director / Officer | — | D | Stock Option (Right to Buy) | 1,776,868 | 1.55 | 2.75M | 0 | — | ↗ |
| 2021-07-26 | Stewart Susan B. | Officer | — | D | Stock Option (Right to Buy) | 33,419 | 1.55 | 51.8K | 0 | — | ↗ |
| 2021-07-26 | SMITH ALAN E | Director | — | D | Common Stock | 0 | 0.00 | — | 32,548 | — | ↗ |
| 2021-07-26 | Nguyen Diem | Director | A-Award | A | Stock Option (Right to Buy) | 28,480 | 8.00 | 227.8K | 28,480 | — | ↗ |
| 2021-07-26 | Meirav Udi | Director | — | D | Stock Option (Right to Buy) | 71,198 | 1.46 | 103.9K | 0 | — | ↗ |
| 2021-07-26 | Martell Christopher | Director | — | D | Stock Option (Right to Buy) | 16,274 | 6.64 | 108.1K | 0 | — | ↗ |
| 2021-07-26 | Manning Paul B | Director | — | I | Series B Preferred Stock | 553,752 | 0.00 | — | 0 | — | ↗ |
| 2021-07-26 | Gandhi Shaan-Chirag C | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-26 | Canepa John J | Officer | — | D | Stock Option (Right to Buy) | 322,710 | 1.55 | 500.2K | 0 | — | ↗ |
| 2021-07-26 | Caffo Nathan | Officer | — | D | Stock Option (Right to Buy) | 296,144 | 1.55 | 459.0K | 0 | — | ↗ |
| 2021-07-26 | Benz Edward J. JR | Director | — | D | Stock Option (Right to Buy) | 4,068 | 1.46 | 5.9K | 0 | — | ↗ |
| 2021-07-26 | Aguilar-Cordova Estuardo | Director / Officer | — | D | Series B Preferred Stock | 162,137 | 0.00 | — | 0 | — | ↗ |
| 2021-07-26 | Aguilar Laura K. | Officer | — | D | Series B Preferred Stock | 56,096 | 0.00 | — | 0 | — | ↗ |
| 2018-12-31 | Martell Christopher | Director | — | I | Warrants to purchase Common Stock | 283,514 | 6.81 | 1.93M | 0 | — | ↗ |
| 2018-12-31 | Manning Paul B | Director | — | I | Warrants to purchase Common Stock | 553,752 | 6.81 | 3.77M | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
54.90M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Paul Peter Tak, M.D., Ph.D., FMedSci, Chief Executive Officer | 743.6K | — | — | 3.92M | 396.7K | 288.3K | 5.34M | 73.27% | ↗ |
| 2 | 2025 | Francesca Barone, M.D., Ph.D. Chief Scientific Officer | 483.3K | — | — | 857.8K | 206.4K | 14.0K | 1.56M | 54.93% | ↗ |
| 3 | 2025 | Charles Schoch Chief Financial Officer | 398.5K | — | — | 826.5K | 232.3K | 13.5K | 1.47M | 56.19% | ↗ |
| 4 | 2024 | Paul Peter Tak, M.D., Ph.D., FMedSci, Chief Executive Officer | 688.9K | — | — | — | 498.1K | 262.2K | 1.45M | 0.00% | ↗ |
| 5 | 2024 | Paul Peter Tak, M.D., Ph.D, FMedSci, Chief Executive Officer | 688.9K | — | — | — | 498.1K | 262.2K | 1.45M | 0.00% | ↗ |
| 6 | 2024 | Francesca Barone, M.D., Ph.D. Chief Scientific Officer | 443.3K | — | — | — | 269.1K | 13.8K | 726.2K | 0.00% | ↗ |
| 7 | 2024 | Seshu Tyagarajan, Ph.D., RAC Chief Technical and Development Officer | 401.4K | — | — | — | 198.1K | 13.8K | 613.2K | 0.00% | ↗ |
| 8 | 2023 | Paul Peter Tak, M.D., Ph.D, FMedSci, Chief Executive Officer | 670.0K | — | 176.5K | 189.6K | 134.0K | 314.7K | 1.48M | 24.65% | ↗ |
| 9 | 2023 | Francesca Barone, M.D., Ph.D. Chief Scientific Officer | 413.0K | — | 110.5K | 89.6K | 80.6K | 13.2K | 706.9K | 28.31% | ↗ |
| 10 | 2023 | Jason A. Amello, Former Chief Financial Officer | 466.0K | — | 123.2K | 89.6K | — | 13.2K | 692.0K | 30.75% | ↗ |
| 11 | 2022 | Paul Peter Tak, M.D., Ph.D, FMedSci, Chief Executive Officer | 670.0K | — | 335.0K | 351.0K | 259.6K | 229.3K | 1.84M | 37.18% | ↗ |
| 12 | 2022 | Seshu Tyagarajan, Ph.D., RAC Chief Technical and Development Officer | 235.4K | 20.0K | 126.0K | 454.8K | 73.2K | 6.6K | 916.0K | 63.40% | ↗ |
| 13 | 2022 | Francesca Barone, M.D., Ph.D. Chief Scientific Officer | 362.2K | — | 155.4K | 234.0K | 144.5K | 12.2K | 908.3K | 42.87% | ↗ |
| 14 | 2021 | Paul Peter Tak, M.D., Ph.D., FMedSci, President and Chief Executive Officer | 545.1K | 85.0K | — | — | 167.5K | 159.2K | 956.8K | 0.00% | ↗ |
| 15 | 2021 | Paul Peter Tak, M.D., Ph.D, FMedSci, Chief Executive Officer | 545.1K | 85.0K | — | — | 167.5K | 159.2K | 956.8K | 0.00% | ↗ |
| 16 | 2021 | Estuardo Aguilar-Cordova, M.D., inf., Ph.D., Founder and Former Chief Executive Officer and Chief Scientific Officer | 520.2K | — | — | — | — | 6.2K | 526.4K | 0.00% | ↗ |
| 17 | 2021 | John Canepa Chief Financial Officer | 370.0K | — | — | — | 74.0K | 5.1K | 449.1K | 0.00% | ↗ |
| 18 | 2021 | Francesca Barone, M.D., Ph.D. Chief Scientific Officer | 259.7K | — | — | — | 101.5K | 3.6K | 364.8K | 0.00% | ↗ |
| 19 | 2020 | Paul Peter Tak, M.D., Ph.D., FMedSci, President and Chief Executive Officer | 134.6K | 85.0K | — | 2.32M | 90.5K | — | 2.63M | 88.19% | ↗ |
| 20 | 2020 | John Canepa Chief Financial Officer | 14.2K | 75.0K | — | 1.23M | — | — | 1.32M | 93.24% | ↗ |
| 21 | 2020 | Estuardo Aguilar-Cordova, M.D., inf., Ph.D., Founder and Former Chief Executive Officer and Chief Scientific Officer | 444.9K | 104.0K | — | — | 191.3K | — | 740.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Paul-Peter Tak FOCIS | President, Chief Executive Officer & Director | 1M | — |
| Seshu Tyagarajan | Chief Technical & Development Officer | 613.2K | — |
| Francesca Barone | Chief Scientific Officer | 497.3K | — |
| Charles Schoch | Senior VP, CFO, Treasurer & Secretary | 412.0K | male |
| Ileen Winick | Chief People Officer | — | female |
| Susan Stewart | Chief Regulatory Officer | — | female |
| William Nichols Garrett | Chief Medical Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CADL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
